Research Article

Formulation and Evaluation of Transdermal Patch of Repaglinide

Table 2

Formulation and evaluation of 32 full factorial design batches.

Batch code 𝑋 1 (HPMC grade) 𝑋 2 (% PVP K30 concentration) 𝑌 1 (tensile strength kg/cm2) 𝑌 2 ( 𝑄 1 )(%) 𝑌 3 ( 𝑄 9 )(%) 𝑌 4 (diffusion coefficient)

F1HPMC E15 LV0.50.389.78061288.915821.043
F2HPMC E15 LV10.4611.3112290.599491.001
F3HPMC E15 LV1.50.6312.2295998.265310.983
F4HPMC K1000.50.4513.3010254.540820.665
F5HPMC K10010.5813.9132763.788270.746
F6HPMC K1001.50.9218.9642975.905610.641
F7HPMC K4M0.50.537.33163348.520410.959
F8HPMC K4M10.848.86224537.984690.656
F9HPMC K4M1.50.959.62755157.704080.853